Cell separation is an integral part of immunology research. Look back with us at some highlights from the last 20 years of immunology research and see how STEMCELL has been helping immunologists isolate pure populations of cells along this journey.
Our first cell isolation technology, StemSep™, is actually column-based, and is invented the same year Peter Doherty and Rolf Zinkernagel won a Nobel Prize for their work on the specificity of immune cells.
This discovery opens doors for researchers to more accurately identify regulatory T cells and their role in maintaining immune tolerance. Learn more about recent advances in immune tolerance research.Learn More
Scientists begin to discover the contributions of adipose tissue-resident immune cells in metabolic disorders. Learn more about recent advances in obesity-associated inflammation.Learn More
The ability to detect variations in the human genome allows immunologists to identify genes associated with autoimmunity. Learn more about the genetic basis of autoimmunity.Learn More
Scientists discover ILC2s as a new cell type that promotes type 2 immune responses and plays a role in the development of allergy. We’ve partnered with Nature Immunology to create a wallchart summarizing the development, plasticity and function of innate lymphoid cells. We are giving them away for free!
We receive Government of Canada support to develop new cell isolation technology that will enable advancements in the study of the immune response to HIV and the development of HIV vaccines.
Groundbreaking studies describing new applications of CRISPR/Cas9 has led to this gene editing technology being named “Breakthrough of the Year”. See how scientists apply this technology to immune cell engineering.Learn More
We develop EasySep™ Release, a new technology that allows scientists to positively select cells then release bound magnetic particles from their isolated cells. This invention enables sequential positive selections to isolate unique and rare cell types.Learn More